Oscar Health Inc
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
OSCR$33.47+4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (in thousands, except share amounts) | March 31, 2024 | December 31, 2023 |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $2,230,799 | $1,870,315 |
| Short-term investments | 616,134 | 689,833 |
| Premiums and accounts receivable (net of allowance for credit losses of $30,600 and $31,600) | 342,904 | 201,269 |
| Risk adjustment transfer receivable | 62,037 | 51,925 |
| Reinsurance recoverable | 242,935 | 241,194 |
| Other current assets | 8,983 | 6,564 |
| Total current assets | 3,503,792 | 3,061,100 |
| Property, equipment, and capitalized software, net | 61,406 | 61,930 |
| Long-term investments | 736,624 | 365,309 |
| Restricted deposits | 29,814 | 29,870 |
| Other assets | 87,217 | 83,271 |
| Total assets | $4,418,853 | $3,601,480 |
| Liabilities and Stockholders' Equity | ||
| Current Liabilities: | ||
| Benefits payable | $1,248,347 | $965,986 |
| Risk adjustment transfer payable | 1,336,022 | 1,056,941 |
| Premium deficiency reserve | 4,332 | 5,776 |
| Unearned premiums | 65,541 | 65,918 |
| Accounts payable and other liabilities | 303,245 | 273,367 |
| Reinsurance payable | 61,938 | 61,024 |
| Total current liabilities | 3,019,425 | 2,429,012 |
| Long-term debt | 298,972 | 298,777 |
| Other liabilities | 66,169 | 67,574 |
| Total liabilities | 3,384,566 | 2,795,363 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' Equity | ||
| Class A common stock ($0.00001 par value; 825,000 thousand shares authorized, 200,497 thousand and 193,875 thousand shares outstanding as of March 31, 2024 and December 31, 2023, respectively) | 2 | 2 |
| Class B common stock ($0.00001 par value; 82,500 thousand shares authorized, 35,514 thousand and 35,514 thousand shares outstanding as of March 31, 2024 and December 31, 2023, respectively) | — | — |
| Treasury stock (315 thousand shares as of March 31, 2024 and December 31, 2023) | (2,923) | (2,923) |
| Additional paid-in capital | 3,736,885 | 3,682,294 |
| Accumulated deficit | (2,699,347) | (2,876,715) |
| Accumulated other comprehensive income (loss) | (2,594) | 1,309 |
| Total Oscar Health, Inc. stockholders' equity | 1,032,023 | 803,967 |
| Noncontrolling interests | 2,264 | 2,150 |
| Total stockholders' equity | 1,034,287 | 806,117 |
| Total liabilities and stockholders' equity | $4,418,853 | $3,601,480 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.